在治疗规划中讨论可能的IVF/ICSI失败及需要多个周期:多周期规划及其对患者和工作人员可接受性的定性研究
该定性研究通过在线焦点小组讨论,探讨患者和生育工作人员对讨论IVF/ICSI可能失败及需要多个周期的看法。结果显示,工作人员通常按周期规划治疗,但双方认为讨论失败可能性和多周期需求有益,可帮助患者做好准备、支持其应对挑战并促进合作。
要点
- 工作人员通常按周期规划IVF/ICSI治疗
- 讨论失败可能性和多周期需求被认为有益
- 从按周期规划转向多周期规划是可能的
核心结论
- 工作人员和患者认为讨论可能的IVF/ICSI失败及需要多个周期有益,可帮助患者做好准备、支持其应对治疗挑战并促进与诊所的合作。
- 研究提示从按周期规划转向多周期规划在IVF规划中是可能的。
研究设计与样本
- 定性焦点小组研究,于2020年4月对生育诊所工作人员和患者慈善机构雇佣的患者倡导者进行焦点小组讨论,于2020年7月和8月对患者进行焦点小组讨论。
- 共12名医护人员、2名患者倡导者和10名患者参与了六次半结构化在线焦点小组讨论。
- 患者纳入标准为参与前8周内有过开始首次/重复刺激IVF/ICSI周期的咨询、年龄18岁或以上(女性年龄上限42岁)、处于异性恋关系且英语流利。
- 使用框架分析法对转录稿进行分析,以识别参与者群体间的共享、独特和不一致主题。
主要发现
- 框架分析在参与者群体中生成四个主题和一个元主题。
- 元主题显示按周期规划IVF是诊所的常规,这影响治疗规划方式以及转向多周期规划的可接受性,后者被认为有益但存在一些忧虑。
- 四个主题为:治疗规划期间信息提供存在异质性;需要改善医患合作;需要缓和对于治疗成功的乐观情绪;对多周期规划的忧虑、益处和偏好。
- 所有患者均无子女,尝试怀孕约3年。
临床怎么用
- 研究提示从按周期规划转向多周期规划在IVF规划中是可能的,但实现这一转变可能需要所有利益相关者(如使用者、工作人员、政策制定者、监管者)合作,通过使用适当基准平衡成本与收益、避免打击乐观情绪、培养合作感并支持患者应对多周期IVF的挑战。
局限性
- 大多数患者为来自私立生育诊所、无既往治疗经验的女性,从社交媒体网站招募,主要与患者支持团体相关。
- 大多数医护人员为来自私立生育诊所的女性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: What are patients' and fertility staff views of talking about possible IVF/ICSI failure and need for multiple cycles in treatment planning? SUMMARY ANSWER: Healthcare professionals (HCPs) typically plan treatment on a cycle-by-cycle basis but HCPs and patients see benefits in talking about possible IVF/ICSI failure and the consequent need for multiple cycles to better prepare patients for this possibility, to support them through treatment challenges and to foster a sense of collaboration with the clinic in achieving the shared goal of treatment success. WHAT IS KNOWN ALREADY: Many patients need more than one round of IVF/ICSI stimulation to achieve their parenthood goals. About 60% of patients are willing to plan for multiple cycles of treatment in advance of treatment engagement. However, it is not clear how patients are informed about the high possibility of failure and the subsequent need for multiple cycles during their treatment planning consultations, and how approaches could be optimized. STUDY DESIGN, SIZE, DURATION: Qualitative focus groups with HCPs working at fertility clinics, patient advocates employed by patient charities (April 2020) and patients (July and August 2020). Patients were eligible if they had had a consultation to start a first/repeat stimulated IVF/ICSI cycle in the 8 weeks prior to participation, were aged 18 or older (upper age limit of 42 years for women), in heterosexual relationships and fluent in English. Eligible HCPs and patient advocates were those employed at a fertility clinic or charity, respectively. PARTICIPANTS/MATERIALS, SETTINGS, METHOD: Focus group topic guides progressed from general questions about fertility consultations to if and how the possibility of treatment failure and need for multiple cycles was introduced and discussed in (attended/own) clinics. After, preferences regarding planning IVF/ICSI on a multi-cycle or cycle-by-cycle basis were explored. Focus groups were recorded, and recordings transcribed and analysed using framework analysis to identify shared, unique and incongruent themes across participant groups. MAIN RESULTS AND THE ROLE OF CHANCE: Twelve HCPs, 2 patient advocates and 10 patients participated in six semi-structured online focus group discussions. All patients were childless and had been trying to conceive for ∼3 years. Framework analysis generated four themes and one meta-theme across participant groups. The meta-theme showed planning IVF on a cycle-by-cycle basis is the norm at clinics and that this affects how treatment is planned and the acceptability of a shift towards planning for multiple cycles, which was perceived as beneficial despite some apprehension. The four themes were: (i) heterogeneity in information provision during treatment planning; (ii) the need for improved HCP-patient collaboration; (iii) the need to temper optimism about treatment success; and (iv) apprehension, benefits and preferences regarding multi-cycle planning. LIMITATIONS, REASONS FOR CAUTION: Most patients were women from private fertility clinics with no previous treatment experience recruited from social media websites, mainly associated with patient support groups. Similarly, most HCPs were women from private fertility clinics. WIDER IMPLICATIONS OF THE FINDINGS: The findings suggest that shifting from cycle-by-cycle to multi-cycle approaches in IVF planning is possible. Achieving this shift, like other shifts in IVF (e.g. single embryo transfer), is likely to require collaboration among all stakeholders (e.g. users, staff, policymakers, regulators) to ensure that costs and benefits are balanced through using appropriate benchmarks, avoiding deflating optimism, fostering a sense of collaboration and supporting patients through challenges of multi-cycle IVF. STUDY FUNDING/COMPETING INTEREST(S): This research is funded by an Investigator-Sponsor Noninterventional Study from Merck Serono Ltd (MS200059_0010), an affiliate of Merck KGaA, Darmstadt, Germany. 'Merck KGaA, Darmstadt, Germany reviewed the manuscript for medical accuracy only before journal submission. The Authors are fully responsible for the content of this manuscript, and the views and opinions described in the publication reflect solely those of the authors'. Prof. J.B. reports personal fees from Merck KGaA, Darmstadt, Germany, Merck AB an affiliate of Merck KGaA, Darmstadt Germany, Theramex, Ferring Pharmaceuticals A/S, grant from Merck Serono Ltd, outside the submitted work and that she is co-developer of Fertility Quality of Life (FertiQoL) and MediEmo app. Dr S.G. reports consultancy fees from Ferring Pharmaceuticals A/S, Access Fertility and SONA-Pharm LLC, and grants from Merck Serono Ltd, an affiliate of Merck KGaA, Darmstadt, Germany. Dr C.H. declares no conflicts of interest. TRIAL REGISTRATION NUMBER: N/A.
引用
- Harrison C, Boivin J, Gameiro S, et al. Talking about possible IVF/ICSI failure and need for multiple cycles in treatment planning: qualitative investigation of multi-cycle planning and its acceptability to patients and staff. Hum Reprod. 2022. PMID: 35040994. doi:10.1093/humrep/deab278
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。